Antithrombotic effects of Intimatan and heparin

被引：0
|
作者：
Tanaka, K
Szlam, F
Katori, N
Vinten-Johansen, J
Cardin, A
Levy, J
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Celsus, Cincinnati, OH USA
来源：
ANESTHESIA AND ANALGESIA | 2004年 / 98卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [21] CONTROL OF HEPARIN THERAPY . SENSITIVITY OF ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR MONITORING ANTITHROMBOTIC EFFECTS OF HEPARIN
    ZUCKER, S
    CATHEY, MH
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1969, 73 (02): : 320 - &
  • [22] COMPARISON OF THE ANTITHROMBOTIC AND HEMORRHAGIC EFFECTS OF HEPARIN AND A NEW LOW-MOLECULAR WEIGHT HEPARIN IN RATS
    ANDRIUOLI, G
    MASTACCHI, R
    BARBANTI, M
    SARRET, M
    HAEMOSTASIS, 1985, 15 (05) : 324 - 330
  • [23] ANTITHROMBOTIC ACTIVITY OF ORAL HEPARIN
    HIEBERT, LM
    WICE, SM
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1108 - 1108
  • [24] ANTITHROMBOTIC PROPHYLAXIS AND THERAPY WITH HEPARIN
    BRUHN, HD
    MEDIZINISCHE WELT, 1990, 41 (05): : 385 - 389
  • [25] ANTITHROMBOTIC PROPHYLAXIS AND THERAPY WITH HEPARIN
    PINDUR, G
    SEYFERT, UT
    WENZEL, E
    THROMBOEMBOLIC RISK AND DYSBALANCE OF HAEMOSTASIS, 1989, : B2 - B4
  • [26] RELATIONSHIP BETWEEN ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN IN EXPERIMENTAL VENOUS THROMBOSIS
    CHIU, HM
    HIRSH, J
    YUNG, WL
    REGOECZI, E
    GENT, M
    BLOOD, 1977, 49 (02) : 171 - 184
  • [27] COMPARING THE ANTITHROMBOTIC EFFECTS OF HEPARIN, ENOXAPARIN AND PROSTACYCLIN DURING CONTINUOUS HEMOFILTRATION
    JOURNOIS, D
    SAFRAN, D
    CASTELAIN, MH
    CHANU, D
    DREVILLON, C
    BARRIER, G
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1990, 9 (04): : 331 - 337
  • [28] ANTITHROMBOTIC AND BLEEDING EFFECTS OF A LOW-MOLECULAR WEIGHT HEPARIN FRACTION
    PANGRAZZI, J
    ABBADINI, M
    ZAMETTA, M
    NAGGI, A
    TORRI, G
    CASU, B
    DONATI, MB
    BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) : 3305 - 3308
  • [29] Intimatan, a heparin cofactor II catalyst, inhibits vessel wall thrombogenicity and intimal hyperplasia more effectively than heparin
    Yang, LY
    Cancel, QV
    Schwartz, D
    Abendschein, D
    Eisenberg, PR
    Van Gorp, CL
    Brister, SJ
    Buchanan, MR
    THROMBOSIS AND HAEMOSTASIS, 1999, : 414 - 414
  • [30] STUDIES ON THE ANTITHROMBOTIC AND HEMORRHAGIC EFFECTS OF DERMATANS, HEPARANS AND HEPARIN IN ANIMAL-MODELS
    HOPPENSTEADT, D
    FAREED, J
    SILBER, I
    NONN, R
    BIANCHINI, P
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 305 - 305
12345